Factors Affecting the Postsurgical Length of Hospital Stay in Patients with Breast Cancer

Abstract

Objective: Breast cancer is the most common malignancy and the most common cause of mortality in women worldwide. In addition to the increasing incidence of breast cancer, the length of hospital stay (LOS) after breast cancer surgery has been decreasing. Because LOS is key in determining hospital usage, the decrease in the use of hospital facilities may have implications on healthcare planning. The purpose of this study was to evaluate the factors affecting postoperative LOS in patients with breast cancer. Materials and Methods:Seventy-six in patients with breast cancer, who had been treated between July 2013 and December 2014 in the General Surgery Clinic of Dicle University, were included in the study. The demographic characteristics of the patients, treatment methods, histopathological features of the tumor, concomitant diseases, whether they underwent neoadjuvant chemotherapy or not, and the length of drain remaining time were retrospectively recorded.Results: There was a correlation between drain remaining time, totally removed lymph node, the number of metastatic lymph node, and LOS. LOS of patients treated with neoadjuvant chemotherapy was longer. The patients who underwent breast-conserving surgery had a shorter LOS. Linear regression analysis revealed that the drain remaining time and the number of metastatic lymph nodes were independent risk factors for LOS.

Evaluation of Clinicopathological Findings and Postoperative Outcomes of Modified Radical Mastectomy in a Tertiary Care Center in Lahore, Pakistan

“…Our study demonstrated that neoadjuvant chemotherapy significantly increased the mean duration of surgery and the mean duration of the drain placement. These findings are in concordance with studies conducted by Gümüş et al 17 and Uslukaya et al 18 Both these studies reported increased mean duration of surgery and mean duration of drain in patients who underwent neoadjuvant chemotherapy. They also reported increased length of hospital stay with neoadjuvant chemotherapy.…”

Perioperative Risk Factors for Prolonged Blood Loss and Drainage Fluid Secretion after Breast Reconstruction

“…Procedures vary in extent based on breast cancer type, hormonal status, and affected lymph nodes. These independent factors can negatively influence the postoperative healing course, as has been previously published [6]. In the case of mastectomy and axillary dissection, postoperative drainage fluid loss and blood loss are significantly higher, and patients require longer in-patient treatment; resulting in longer convalescence before further treatment can be initiated [20,30].…”

“…Therefore, identifying the perioperative risk factors for prolonged wound healing or hospital stay are of great importance to potentially optimize the postoperative course and minimize the above risks. Some of these aspects are oncology-related (e.g., mastectomy type, or axillary dissection) and cannot be influenced, whereas others are not and may be subject to optimization [5][6][7][8][9][10][11].…”

Breast Sarcomas—How Different Are They from Breast Carcinomas? Clinical, Pathological, Imaging and Treatment Insights

“…This result cannot be interpreted as a statistically significant result due to the small cohort, but can be explained by the prevalence of less extensive surgical procedures (without regional lymphadenectomy) performed in BS cases. Our BC patients mainly underwent radical surgery, which is more complex and had a longer postoperative recovery period and greater risk of early complications [ 39 ]. As long as two decades ago, it was reported that LOS in patients with BC decreased from 10–14 days to 5–7 days [ 40 , 41 , 42 , 43 , 44 ].…”